Wuxi Beta Conquers Key Technology of Isotope Labeling to Help New Drug Research and Development-Torch Center of Ministry of Science and Technology
Release time:
2019-04-15
Jiangyin High-tech Zone: Wuxi Beta Conquers Key Technology of Isotope Labeling to Help New Drug Research and Development March 26, 2019 Source: China High-tech Industry Herald Website: http://www.ctp.gov.cn/kjb/dfdt/201903/bde017961f1044aa833792f9e823ef02.shtml近日获悉,江阴高新区企业无锡贝塔医药科技有限公司与四川科伦药物研究院签订科技服务合作协议 。 The new drug research and development department of Sichuan Kelun Pharmaceutical Research Institute is negative.
Jiangyin High-tech Zone: Wuxi Beta to conquer the key technology of isotope labeling to help new drug research and development.
March 26, 2019 Source: China High-tech Industry Herald
Website:http://www.ctp.gov.cn/kjb/dfdt/201903/bde017961f1044aa833792f9e823ef02.shtml
Recently, it was learned that Wuxi Beta Pharmaceutical Technology Co., Ltd., an enterprise in Jiangyin High-tech Zone, signed a scientific and technological service cooperation agreement with Sichuan Kelun Pharmaceutical Research Institute. The head of the new drug research and development department of the Sichuan Kelun Pharmaceutical Research Institute recognized Wuxi Beta's radioisotope labeling work and believed that Wuxi BetaIn 2018, the three small molecular compounds labeled with carbon -14(C-14) and tritium (H-3) isotopes for Sichuan Kelun Pharmaceutical Research Institute are more efficient, cheaper and more convenient to communicate than similar foreign products. We are willing to establish a long-term cooperative relationship with Wuxi Beta.
In 2018, Wuxi Beta provided more than 10 successful markers for new drugs such as Sichuan Kelun Pharmaceutical Research Institute, Jiangsu Hengrui Pharmaceutical, Jiangsu Haosen Pharmaceutical, Nanjing Shenghe Pharmaceutical, Beijing Sailintai Pharmaceutical, Fujian Haixi Pharmaceutical and other leading pesticide research and development enterprises such as Qingdao Qingyuan. Since then, China's new drug and pesticide research has ended its history of being sent abroad for isotope labeling and has been well received by customers.
It is understood that Wuxi Beta Pharmaceutical Technology Co., Ltd. was founded by Dr. Li Gang, the second prize winner of the National Science and Technology Progress Award and a returned entrepreneur from the United States,In November 2008, it entered the Biopharmaceutical Industrial Park of Jiangyin High-tech Zone. It is a leading enterprise in China specializing in the research and development and labeling services of carbon -14, carbon -13 and other isotope labeled compounds.
In recent years, Wuxi Beta Pharmaceutical Technology Co., Ltd. has solved the carbonBottlenecks in the preparation and supply of -14 source materials and labeled precursor compounds; overcome the technical difficulties in the preparation and labeling of carbon -14 labeled key compounds; and realize the localization of urea-14C and urea-13C, the key raw materials for the detection of Helicobacter pylori in the stomach as the "gold standard. At the same time, it also conquered the preparation technology of isotope internal standard for neonatal genetic metabolic disease screening and vitamin D deficiency detection, breaking a number of international import restrictions at one stroke and realizing domestic substitution.
Website:http://www.ctp.gov.cn/kjb/dfdt/201903/bde017961f1044aa833792f9e823ef02.shtml
Related News
Tel.：0510-81695383
E-mail：chengcaihong@beitalab.com
Fax：0510-81602153
Add：70 Dongsheng West Road, Jiangyin City, Jiangsu Province
Postal Code: 214437
Copyright©2024 Wuxi Beita Pharmatech Co., Ltd. Business License
